Edition:
United States

Cellectar Biosciences Inc (CLRB.OQ)

CLRB.OQ on NASDAQ Stock Exchange Capital Market

7.38USD
4:00pm EDT
Change (% chg)

$6.63 (+885.31%)
Prev Close
$0.75
Open
$11.20
Day's High
$12.76
Day's Low
$7.16
Volume
677,285
Avg. Vol
5,492
52-wk High
$20.50
52-wk Low
$5.80

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.207
FY 2017 Dec '17 0.00 -0.322
Sep '17 0.00 -0.258
Jun '17 0.00 -0.232
Mar '17 0.00 -0.241
FY 2016 Dec '16 0.00 -0.344
Sep '16 0.00 -0.426
Jun '16 0.00 -0.493
Mar '16 0.00 0.910
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-19 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Sep-18 1 -0.16 -0.16 -0.16 -0.22
Quarter Ending Dec-18 1 -0.16 -0.16 -0.16 -0.21
Year Ending Dec-18 1 -0.73 -0.73 -0.73 -0.89
Year Ending Dec-19 1 -0.62 -0.62 -0.62 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.21 33.15
P/E High - Last 5 Yrs. -- 41.80 47.15
P/E Low - Last 5 Yrs. -- 23.83 25.03
Beta 0.92 0.83 0.82
Price to Sales (TTM) -- 3.62 8.04
Price to Book (MRQ) 1.88 3.77 4.28
Price to Tangible Book (MRQ) 2.27 4.75 6.01
Price to Cash Flow (TTM) -- 19.97 22.37
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.86 1.72
Dividend Yield - 5 Year Avg -- 1.54 1.46
Dividend 5 Year Growth Rate -- -9.59 -6.51
Payout Ratio(TTM) -- 48.91 47.12

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.55 4.77
Sales (TTM) vs TTM 1 Yr. Ago -- 10.18 12.38
Sales - 5 Yr. Growth Rate -- 6.97 7.73
EPS (MRQ) vs Qtr. 1 Yr. Ago 14.10 54.40 45.88
EPS (TTM) vs TTM 1 Yr. Ago 32.25 -- --
EPS - 5 Yr. Growth Rate -- 6.42 7.99
Capital Spending - 5 Yr. Growth Rate 28.83 6.91 7.69

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.60 2.57
Current Ratio (MRQ) 3.63 3.69 3.65
LT Debt to Equity (MRQ) 0.02 10.82 13.25
Total Debt to Equity (MRQ) 0.06 14.58 17.43
Interest Coverage (TTM) -- 39.59 35.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.45 55.10
Gross Margin - 5 Yr. Avg. -- 53.07 53.12
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.54 15.67
Operating Margin (TTM) -- 14.30 -0.48
Operating Margin - 5 Yr. Avg. -- 14.20 10.86
Pre-Tax Margin (TTM) -- 14.58 1.32
Pre-Tax Margin - 5 Yr. Avg. -- 14.43 10.99
Net Profit Margin (TTM) -- 11.15 -1.97
Net Profit Margin - 5 Yr. Avg. -- 10.77 7.35
Effective Tax Rate (TTM) -- 21.73 20.80
Effective Tax Rate - 5 Yr. Avg. -- 23.85 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 858,179,089 746,896,227
Net Income/Employee (TTM) -- 100,194,450 87,146,227
Receivable Turnover (TTM) -- 5.87 5.99
Inventory Turnover (TTM) -- 2.58 3.70
Asset Turnover (TTM) 0.00 0.90 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -113.82 10.82 10.49
Return on Assets - 5 Yr. Avg. -79.65 11.59 11.10
Return on Investment (TTM) -132.51 13.66 13.23
Return on Investment - 5 Yr. Avg. -123.05 15.03 14.34
Return on Equity (TTM) -151.68 15.51 15.27
Return on Equity - 5 Yr. Avg. -139.34 16.27 15.70
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 21.47 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cellectar Biosciences Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 7.61%
# of Holders: 21
Total Shares Held: 1,348,024
3 Mo. Net Change: 67,898
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.